Net additions (releases) charged to costs and expenses
Medtronic Net additions (releases) charged to costs and expenses increased by 3.7% to $28.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 55.6%, from $18.00M to $28.00M. Over 4 years (FY 2021 to FY 2025), Net additions (releases) charged to costs and expenses shows relatively stable performance with a -1.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase suggests deteriorating customer credit quality or a more conservative accounting approach to bad debt.
Detailed definition
An expense recognized to account for the portion of accounts receivable that the company estimates will not be collected...
Peer comparison
Standard across all industries; benchmarked against historical bad debt ratios.
other_provision_for_doubtful_accountsHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $25.00M | $15.00M | $26.00M | $8.00M | $9.00M | $15.00M | $22.00M | $17.00M | $19.00M | $21.00M | $24.00M | $17.00M | $28.00M | $18.00M | $48.00M | $30.00M | $27.00M | $28.00M |
| QoQ Change | — | -40.0% | +73.3% | -69.2% | +12.5% | +66.7% | +46.7% | -22.7% | +11.8% | +10.5% | +14.3% | -29.2% | +64.7% | -35.7% | +166.7% | -37.5% | -10.0% | +3.7% |
| YoY Change | — | — | — | — | -64.0% | +0.0% | -15.4% | +112.5% | +111.1% | +40.0% | +9.1% | +0.0% | +47.4% | -14.3% | +100.0% | +76.5% | -3.6% | +55.6% |
Net additions (releases) charged to costs and expenses at Other Companies
Frequently Asked Questions
- What is Medtronic's net additions (releases) charged to costs and expenses?
- Medtronic (MDT) reported net additions (releases) charged to costs and expenses of $28.00M in Q2 2025.
- How has Medtronic's net additions (releases) charged to costs and expenses changed year-over-year?
- Medtronic's net additions (releases) charged to costs and expenses increased by 55.6% year-over-year, from $18.00M to $28.00M.
- What is the long-term trend for Medtronic's net additions (releases) charged to costs and expenses?
- Over 4 years (2021 to 2025), Medtronic's net additions (releases) charged to costs and expenses has grown at a -1.6% compound annual growth rate (CAGR), from $131.00M to $123.00M.
- What does net additions (releases) charged to costs and expenses mean?
- The estimated amount of customer debt that will likely go unpaid.